Joseph R. Nevins
Affiliations: | Molecular Genetics and Microbiology | Duke University, Durham, NC |
Area:
Genetics, Systematic BiologyGoogle:
"Joseph Nevins"Parents
Sign in to add mentorWolfgang (Bill) Karl Joklik | grad student | 1976 | Duke | |
(Ph.D.: STUDIES ON THE STRUCTURE AND SYNTHESIS OF VACCINIA VIRUS MESSENGER-RNA.) |
Children
Sign in to add traineeAlison R. Meloni | grad student | 2001 | Duke |
Heather G. LaBreche | grad student | 2011 | Duke |
James V DeGregori | post-doc | (Chemistry Tree) | |
Stephen H. Devoto | post-doc | (Neurotree) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Jiang X, Nevins JR, Shats I, et al. (2015) E2F1-Mediated Induction of NFYB Attenuates Apoptosis via Joint Regulation of a Pro-Survival Transcriptional Program. Plos One. 10: e0127951 |
Dong P, Maddali MV, Srimani JK, et al. (2014) Division of labour between Myc and G1 cyclins in cell cycle commitment and pace control. Nature Communications. 5: 4750 |
Shats I, Gatza ML, Liu B, et al. (2013) FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function. Cancer Research. 73: 6056-67 |
Liu B, Shats I, Angus SP, et al. (2013) Interaction of E2F7 transcription factor with E2F1 and C-terminal-binding protein (CtBP) provides a mechanism for E2F7-dependent transcription repression. The Journal of Biological Chemistry. 288: 24581-9 |
Keenan MM, Liu B, Wu J, et al. (2013) Abstract A18: Genetic elements of cancer cell survival in tumor microenvironment stresses Molecular Cancer Therapeutics. 12 |
Leung JY, Nevins JR. (2012) E2F6 associates with BRG1 in transcriptional regulation. Plos One. 7: e47967 |
Riedel RF, Porrello A, Pontzer E, et al. (2012) Retraction in part: A genomic approach to identify molecular pathways associated with chemotherapy resistance. Molecular Cancer Therapeutics. 11: 1214-5 |
Angus SP, Nevins JR. (2012) A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest. Oncogene. 31: 4709-17 |
Leung JY, Andrechek ER, Cardiff RD, et al. (2012) Heterogeneity in MYC-induced mammary tumors contributes to escape from oncogene dependence. Oncogene. 31: 2545-54 |
Friedman DR, Rempel RE, Jiang X, et al. (2012) Modeling Variation in the Human Lymphoma Microenvironment with the Eμ-Myc Mouse Model Blood. 120: 789-789 |